China Scar Treatment Market – Insights
Scars are marks created on the top layer of skin during healing of damaged tissues or due to wounds. Topical products and various procedures are used for the treatment of scars such as surgery, steroid injections, cryotherapy, and pressure treatment or gel pads with silicone.
China scar treatment market is estimated to account for US$ 5,317.7 Mn in terms of value by the end of 2027.
China Scar Treatment Market: Drivers
Increasing number of accidents and surgeries is expected to boost growth of China scar treatment market over the forecast period. For instance, according to Ministry of State Administration China, China recorded 38,000 deaths due to workplace accidents in 2017.
Increasing incidents of burns is also expected to boost growth of the market over the forecast period. For instance, in February 2019, a study published in the journal Experimental and Therapeutic Medicine reported that 13,205 burn patients were admitted to the Burn Research Institute of Southwest Hospital of the Army Medical University, China during 2009-2016.
Laser treatment segment held dominant position in china scar treatment market in 2018, accounting for 45%% share in terms of volume, followed by topical treatment.
China Scar Treatment Market: Restraints
Scar treatment can lead to several complications, which is expected to hinder growth of China scar treatment market. Although local manufacturers in China offer a wide range of injectable filler and steroids injections, the quality of these products is questionable mainly due to the lack of regulatory standards for such products in the country. Moreover, wrong dosage or medication can lead to complications such as skin infections, redness, itching, and pain.
High cost of laser treatment is also expected to hamper growth of the market over the forecast period.
China Scar Treatment Market: Opportunities
Increasing R&D in scar treatment is expected to offer lucrative growth opportunities for players in China scar treatment market. For instance, in September 2018, researchers from Changhai Hospital affiliated to Navy Medical University, China, appraised, drafted, reviewed, and finalized a consensus to standardize and improve scar prevention and treatment in China. The consensus was published in journal Burns and Trauma of BMC.
Moreover, technological advancements in the treatment of organ scarring is also expected to boost growth of the market. For instance, in December 2019, in the journal Cell Reports, researchers from the University of California Los Angeles reported development of accurate model of organ scarring using stem cells in a lab.
Aesthetic Lasers segment in china scar treatment market was valued at US$ 1,119.8 Mn in 2018 and is expected to reach US$ 2,717.31 Mn by 2027 at a CAGR of 10.4% during the forecast period.
Market Trends/Key Takeaways
China scar treatment is witnessing increasing use of silicon-based products for the treatment of scars. Silicone gel is highly effective for the treatment of various types of scars such as superficial scars, keloids, and hypertrophic. It contains silicon dioxide, polymer (polysiloxanes), and volatile components. Silicone gel reduces discomfort and itching associated with scars.
Majority of the populace in China prefers use of natural oils for reduction of scars as these oils are cost effective and have very few side effects. Some of these oils include, coconut oil, lavender oil, tee tree oil, and olive oil. Moreover, use of Rosehip seed oil for scar treatment is an emerging trend in China. Rosehip seed oil is effective in reducing appearance of scars and improving the complexion and health of the skin.
China’s FDA lists regulations for topical applications under the Presidential order no: 45, control over drugs segment. The drug regulatory department under the State Council regulates drug administration in China.
Labelling requirements for topical applications:
Apart from manufacturing drugs adhering to GMP regulations in China, the following are specific labelling requirements for topical drugs:
- A label has to be printed or stuck on drugs together with a ‘drug insert sheet’
- The ‘insert sheet’ needs to mention the name of the drug as registered in China
- The label should also contain names of active ingredients, product batch number, production date, date of expiry, strength, manufacturer name, approval number indications or functions, contraindications, adverse drug reactions, and precautions
- The label should also have the specified mark for topical application as given by the State
China Scar Treatment Market: Competitive Landscape
Major players operating in China scar treatment market include, Cynosure, Inc., Syneron Medical Ltd., Mölnlycke Health Care, Ostar Beauty Sci-Tech Co., Ltd., Shanghai Fosun Pharmaceutical Co. Ltd., Beijing Toplaser Technology Co., Ltd., Merz Pharma, and Luca Pharmaceuticals.
Key players in the market are focused on conducting clinical trials to expand their product portfolio. For instance, HTC Corporation’s HTC VIVE, a VR system is under clinical trial for assessing the effect of virtual reality technology on decreasing the acute pain of scar treatment with fractional laser under local anesthesia. The study is expected to be completed in December 2020.
Major institutes in China are focused on R&D in treatment of caesarean section scars. For instance, in March 2019, Maternal and Child Health Hospital of Foshan completed a study that assessed the efficacy and safety of perinatal tissue mesenchyme stem cells in the treatment for caesarean section scars.